Simplifying Global Compliance
FDAnews Device Daily Bulletin
3I BACKS ULTHERA IN BRINGING THERAPEUTIC ULTRASOUND PRODUCT TO COSMETICS MARKET
Dec. 16, 2005
Ulthera, a therapeutic ultrasound medical device company targeting the cosmetics
market, today announced that it has raised $5.5m in Series A funding from world
leading venture capital firm, 3i. 3i Investors Allan Ferguson and Paul Badawi
join Ulthera co-founder, CEO and Chairman, Michael Slayton on the board.
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing